TV

Thikkur Venkatesh Ashwitha

Active Director Director DIN 11339808
DIN 11339808 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Thikkur Venkatesh Ashwitha

Data last updated:

Thikkur Venkatesh Ashwitha is a Director at Aventus Drugs Private Limited (since 2025). The company operates in Pharma.

DIN 11339808
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aventus Drugs Private Limited U46497KA2025PTC209625
Director13 Oct 20252025Active

Board colleagues of Thikkur Venkatesh Ashwitha

NameDINCompanyDesignation
Mallanduru Srinivas Gowda Lohith11339807Aventus Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aventus Drugs Private Limited
Premium access

Shareholding and investment profile for Thikkur Venkatesh Ashwitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thikkur Venkatesh Ashwitha

Thikkur Venkatesh Ashwitha currently holds 1 directorship: Aventus Drugs Private Limited (Director, since 13 Oct 2025).

Thikkur Venkatesh Ashwitha was first appointed on 13 Oct 2025 as Director at Aventus Drugs Private Limited.

The current boards of Thikkur Venkatesh Ashwitha's companies include Mallanduru Srinivas Gowda Lohith (Aventus Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available